Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the routine health screening market?

The value of the routine health screening market has been bolstered considerably in past years. The forecast predicts an escalation from $54.28 billion in 2024 to $58.45 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this historic period growth include an increased understanding of preventive healthcare, a rising occurrence of chronic conditions, expanding government programs for early disease identification, the growth in the aging population worldwide, and advancements in the healthcare infrastructure.

What will be the routine health screening market size in the future?

Over the next few years, the market size for routine health screening is anticipated to witness robust growth, reaching $77.76 billion by 2029 at a CAGR of 7.4%. This growth during the forecast period can be linked to heightened adoption of customized medicine and a rising focus on managing chronic diseases. Additional contributing factors include the broadening of healthcare availability in burgeoning markets, increased healthcare expenditure, and more substantial public and private investments in health prevention programs. Trending phenomena to anticipate throughout the forecast period are the incorporation of artificial intelligence for superior diagnostic precision, broadening of health screening amenities via telemedicine platforms, an elevated emphasis on preventive attention propelled by public health projects, amplified patient involvement through mobile health apps and digital health platforms, and the refinement of advanced biomarker-based screening techniques.

Get your routine health screening market report here!

https://www.thebusinessresearchcompany.com/report/routine-health-screening-global-market-report

What main drivers are fueling expansion in the routine health screening market?

The boom in conscious preventive healthcare is anticipated to accelerate the expansion of the routine health screenings market. Preventive healthcare consists of strategies and actions intended to halt diseases and health conditions in their tracks through early detection, lifestyle alterations, and preemptive treatments. The comprehension of preventive healthcare has expanded owing to its benefits in nipping diseases in the bud, improving health results, and saving costs, fueled by enhanced public understanding and medical progress. Routine health check-ups support preventive healthcare by spotting possible health problems ahead of time, enabling prompt actions, and minimizing the risk of grave diseases. For example, as reported by the National Health Service (NHS), a state-funded healthcare system based in the UK, around 2,302,400 diagnostic assessments were performed in March 2023, showing a surge of 223,100 tests in comparison to March 2022. By the end of March 2023, the count of patients on the waiting list for a crucial diagnostic examination touched 1,628,300, marking a rise of 59,400 compared to March 2022. Therefore, the surging cognizance of preventive healthcare is steering the growth in the routine health screenings market.

What key areas define the segmentation of the global routine health screening market?

The routine health screening market covered in this report is segmented –

1) By Test Type: Blood Glucose Test, Kidney Function Test, Bone Profile Test, Electrolyte Test, Liver Function Test, Lipid Profile Test, Other Test Types

2) By Sample Type: Blood, Urine, Serum, Saliva, Other Sample Types

3) By Technology: Quantitative Polymerase Chain Reaction (QPCR), Quantitative Fluorescence In Situ Hybridization (Q-FISH), Immunoassays, Medical Imaging, Single Telomere Length Analysis (STELA), Other Technologies

4) By Sample Collection Sites: Hospitals, Homes, Diagnostic Laboratories, Offices, Other Sample Collection Sites

Subsegments:

1) By Blood Glucose Test: Fasting Blood Glucose Test, HbA1c Test, Continuous Glucose Monitoring

2) By Kidney Function Test: Serum Creatinine Test, Blood Urea Nitrogen (BUN) Test, Urinalysis

3) By Bone Profile Test: Serum Calcium Test, Phosphate Test, Bone Mineral Density (BMD) Test

4) By Electrolyte Test: Serum Sodium Test, Serum Potassium Test, Serum Chloride Test

5) By Liver Function Test: Alanine Aminotransferase (ALT) Test, Aspartate Aminotransferase (AST) Test, Bilirubin Test

6) By Lipid Profile Test: Total Cholesterol Test, Low-Density Lipoprotein (LDL) Test, High-Density Lipoprotein (HDL) Test

7) By Other Test Types: Thyroid Function Test, Complete Blood Count (CBC), Prostate-Specific Antigen (PSA) Test

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20618&type=smp

Who are the dominant players expanding their reach in the routine health screening market?

Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group

How are evolving market trends shaping routine health screening Strategies?

To secure a competitive advantage in the standard health screenings market, top-notch companies are looking to innovate with advanced solutions, including those for lung cancer detection. Medical procedures for early-stage lung cancer detection in possibly high-risk individuals, prior to symptom onset, are what these lung cancer screening tests entail. An instance of such an innovation happened in October 2023 when DELFI Diagnostics Inc., a leading US-based diagnostic technology firm, unveiled FirstLook Lung, a trailblazing blood test to enhance lung cancer screening. Employing fragmentomics, FirstLook Lung scrutinizes cell-free DNA (cfDNA) patterns in blood specimens, using sophisticated machine learning to discern between cancerous and benign patterns. A 99.7% negative predictive value (NPV) allows the test to accurately pinpoint likely lung cancer cases, reducing the requirement for unnecessary LDCT scans. As a part of commonplace blood tests, FirstLook Lung aspires to magnify screening rates, mainly in underserviced communities, boasting a versatile, learning, whole-genome machine platform with the capacity for international extension to different types of cancers and treatment observation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20618

Which regions are emerging as leaders in the routine health screening market?

North America was the largest region in the routine health screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Equine Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/equine-healthcare-global-market-report

Connected Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/connected-healthcare-global-market-report

Consumer Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/consumer-healthcare-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: